TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the “Investors” section and the “Events and Presentations” tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event. About Prestige Consumer Healthcare Inc. Prestige Consumer Healthcare Inc. (NYSE: PBH) is a leading consumer healthcare...

Tórshavn, Faroe Islands, 2026-09-08 (GLOBE NEWSWIRE) — Today P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) held an Extraordinary General Meeting in Tórshavn, Faroe Islands.Petur Even Djurhuus was elected Chairman of the Meeting. The Board proposed for the election as board members: Mourits Joensen, Zvonimir Mrdalo and Halgir Winther Arge. The General Meeting elected the board members proposed by the Board. Proposal to change the Articles of Association of the Company to give the Board of Directors authorization to increase the Share Capital by subscription of new Share Capital with pre-emptive rights for the existing shareholders. The proposed change was presented and approved by the General Meeting.Proposal to change the Articles of Association of the Company to give the Board of Directors authorization to increase the Share...

TAMPA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) — Inhibitor Therapeutics, Inc. (OTCQB: INTI) (“Inhibitor” or the “Company”) today highlighted several important developments disclosed in its Quarterly Report on Form 10-Q filed August 14, 2026, and encouraged stockholders and other interested parties to review the filing for a more complete discussion of the Company’s progress. Recent progress includes a revised regulatory strategy for itraconazole in Basal Cell Carcinoma Nevus Syndrome (“BCCNS” or “Gorlin Syndrome”), descriptive characterization of prospectively collected measurements from the completed Phase IIb HP2001 study, continued FDA engagement, development of a proposed commercial formulation, a new provisional patent filing, outside scientific support and a favorable Delaware...

ROCHESTER, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) — Constellation Brands (NYSE: STZ), a leading U.S.-based total beverage alcohol company, announced today that it has given notice for full redemption prior to maturity of all of its outstanding 4.350% Senior Notes due 2027 (CUSIP Number: 21036P BK3) to be effected on September 18, 2026. As of September 8, 2026, there were $600.0 million in aggregate principal amount of the notes outstanding. The redemption price for the notes, payable in cash, will be calculated pursuant to the formula set forth in the supplemental indenture relating to the notes. This press release shall not constitute a notice of redemption of the notes. Information concerning the terms and conditions of the redemption of the notes is described in the notice distributed to holders of the notes by the trustee under...

TEL AVIV, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) — Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, today announced a 1-for-20 reverse share split of its ordinary shares, no par value per share (the “Ordinary Shares”). The reverse share split and corresponding share capital adjustment will become effective at 11:59 p.m. Eastern Time on September 10, 2026. The Ordinary Shares will begin trading on a split-adjusted basis on The Nasdaq Stock Market LLC (“Nasdaq”) at the open of business on Friday, September 11, 2026, under the existing trading symbol “GAUZ,” but the Ordinary Shares will trade under a new CUSIP number, M4757U114. As a result of the reverse share split, every 20 issued and outstanding Ordinary Shares will automatically be converted into one Ordinary Share....

CALGARY, Alberta, Sept. 08, 2026 (GLOBE NEWSWIRE) — Crown Point Energy Inc. (TSX-V:CWV) (“Crown Point” or the “Company“) announces that it has been advised by the TSX Venture Exchange (the “TSXV“) that its listing will be transferred to the NEX Board (the “NEX“) of the TSXV effective as of the opening of trading on September 11, 2026. The transfer of the listing to NEX is being made as a result of the Company not meeting the TSXV’s Tier 2 continued listing requirements due to Liminar Energía S.A. having acquired more than 90% of the Company’s common shares, resulting in less than 10% of the Company’s common shares being in the “public float”. NEX is a separate trading board of the TSXV that provides a trading forum for companies that have fallen below...

NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) — Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 2026 Jefferies Healthcare Services and Technology Conference on Monday, September 14, 2026, at 2:15 pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company’s website at https://ir.stratacritical.com/. About Strata Critical Medical Strata Critical Medical provides time-critical logistics solutions and specialized medical services to healthcare providers across the United States, strategically expanding its portfolio of services through acquisition and organic growth. Strata’s subsidiary, Trinity Medical Solutions, is an industry leader...

Stransky brings more than two decades of brand-building experience and expertise in data-driven marketing and AI-powered solutionsBOSTON BEER APPOINTS ALLISON STRANSKY CHIEF MARKETING OFFICER EFFECTIVE OCTOBER 12Stransky brings more than two decades of brand-building experience and expertise in data-driven marketing and AI-powered solutionsBoston, Sept. 08, 2026 (GLOBE NEWSWIRE) — The Boston Beer Company, Inc. (NYSE: SAM) today announced the appointment of Allison Stransky to the Chief Marketing Officer role, effective October 12, 2026.   Stransky brings more than 20 years of experience to Boston Beer, including a unique blend of consumer brand-building expertise and data-driven digital marketing capabilities that will further strengthen, modernize, and evolve the company’s marketing approach. Stransky will be responsible...